Showing results (161-170 of 232) with videos related to
Sort By:
Pageof 24
Journal of Clinical Psychopharmacology|April 19, 2000
Pharmacologic profile of perphenazine's metabolitesR A Sweet, B G Pollock, B H Mulsant, et al.Addictive Behaviors|May 5, 2000
Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up studyJ R Cornelius, I M Salloum, R F Haskett, et al.Journal of the American Academy of Child and Adolescent Psychiatry|November 9, 2000
Parent-child bonding and family functioning in depressed children and children at high risk and low risk for future depressionD Stein, D E Williamson, B Birmaher, et al.Psychopharmacology Bulletin|January 1, 1993
Fluoxetine trial in suicidal depressed alcoholicsJ R Cornelius, I M Salloum, M D Cornelius, et al.Addictive Behaviors|April 6, 1999
Fluoxetine versus placebo for the marijuana use of depressed alcoholicsJ R Cornelius, I M Salloum, R F Haskett, et al.Archives of General Psychiatry|November 1, 1992
Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal childrenN D Ryan, B Birmaher, J M Perel, et al.CNS Spectrums|August 30, 2003
The establishment of a brain bank for the study of late-life depression: a feasibility study of factors facilitating consentC McFarland, R A Sweet, S T DeKosky, et al.Depression and Anxiety|March 10, 2001
Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderlyG M Bump, B H Mulsant, B G Pollock, et al.Psychiatry Research|December 6, 2000
The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcomeC R Hernandez, G S Smith, P R Houck, et al.The American Journal of Psychiatry|December 1, 2001
Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depressionE M Whyte, B G Pollock, W R Wagner, et al.Pageof 24